Upstream Processing

May 30, 2017
By BioPharm International Editors
BioVectra will open its new microbial fermentation and complex chemistry site, including the capability to handle high-potency APIs, by the end of 2017.
May 11, 2017
By BioPharm International Editors
MilliporeSigma released a new surface-active nonionic polymer to ensure lot-to-lot consistency.
May 01, 2017
BioPharm International
Improving the bioreactor growth environment increases the rigor of bioprocessing runs.
May 01, 2017
BioPharm International
Can bioprocessing runs be consistently replicated in an inherently variable production environment?
Apr 11, 2017
GE Healthcare continues to ramp up its offerings in the bioprocessing space with the purchase of Asymptote and a continued partnership with Zenith Technologies.
Apr 01, 2017
BioPharm International
OrlaSURF technology can be used for the development of target-binding assays to monitor the binding of an ADC to its antigen.
Mar 01, 2017
BioPharm International
The decision to use disposable bioreactors is now driven by commercial rather than technological considerations.
Feb 27, 2017
By BioPharm International Editors
Sanofi and Lonza formed a joint venture to build and operate a large-scale mammalian cell culture facility for monoclonal antibody production in Visp, Switzerland.
Feb 22, 2017
By BioPharm International Editors
CellGenix will add R&D, production, and warehouse space in Freiburg, Germany for GMP-grade raw materials for cell therapy, gene-therapy, and tissue-engineered products.
Feb 21, 2017
By BioPharm International Editors
Under the agreement, Abzena will manufacture magacizumab, an antibody created using the ‘Abzena inside’ Composite Human Antibody technology.
native1_300x100
lorem ipsum